Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, Jennifer Cocohoba, PharmD, and Jason Schafer, PharmD, MPH, discuss key studies from IAS 2021 that will influence the role of the pharmacist in the treatment and prevention of HIV. Their discussion includes analyses of:
Department of Clinical Pharmacy
University of California, San Francisco
Women's HIV Program
University of California San Francisco Medical Center
San Francisco, California
Professor and Vice Chair
Jefferson College of Pharmacy
Thomas Jefferson University
This program has been made available online.
Listen to Drs Jill Blumenthal and Jennifer Cocohoba discuss ART tolerability in transgender persons and the many factors to consider, from Clinical Care Options (CCO)
Discussion of barriers and calls to action for providing patient-centered HIV care in Malaysia from a healthcare professional and a patient advocate, from Clinical Care Options (CCO)
Dr Sylvia Ojoo discusses data on cryptococcal meningitis in people with HIV from the fall 2022 HIV conferences, from Clinical Care Options (CCO)
Clinical Care Options (CCO) expert audio: Drs Chloe Orkin and Babafemi Taiwo discuss new HIV data presented at IDWeek and HIV Glasgow 2022